257 related articles for article (PubMed ID: 9457811)
21. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
[TBL] [Abstract][Full Text] [Related]
22. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
[TBL] [Abstract][Full Text] [Related]
23. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
Prados MD; Larson DA; Lamborn K; McDermott MW; Sneed PK; Wara WM; Chang SM; Mack EE; Krouwer HG; Chandler KL; Warnick RE; Davis RL; Rabbitt JE; Malec M; Levin VA; Gutin PH; Phillips TL; Wilson CB
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):57-63. PubMed ID: 9422558
[TBL] [Abstract][Full Text] [Related]
24. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2.
Gutin PH; Prados MD; Phillips TL; Wara WM; Larson DA; Leibel SA; Sneed PK; Levin VA; Weaver KA; Silver P
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):601-6. PubMed ID: 1651302
[TBL] [Abstract][Full Text] [Related]
25. Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume.
Simon JM; Cornu P; Boisserie G; Hasboun D; Tep B; Hardiman C; Valery CA; Delattre JY; Dormont D; Baillet F; Mazeron JJ
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):67-74. PubMed ID: 12007943
[TBL] [Abstract][Full Text] [Related]
26. Survival and functional status after resection of recurrent glioblastoma multiforme.
Barker FG; Chang SM; Gutin PH; Malec MK; McDermott MW; Prados MD; Wilson CB
Neurosurgery; 1998 Apr; 42(4):709-20; discussion 720-3. PubMed ID: 9574634
[TBL] [Abstract][Full Text] [Related]
27. Clinical trial of external beam-radiotherapy combined with daily administration of low-dose cisplatin for supratentorial glioblastoma multiforme--a pilot study.
Shinoda J; Sakai N; Hara A; Ueda T; Sakai H; Nakatani K
J Neurooncol; 1997 Oct; 35(1):73-80. PubMed ID: 9266443
[TBL] [Abstract][Full Text] [Related]
28. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
[TBL] [Abstract][Full Text] [Related]
29. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):820-4. PubMed ID: 17499453
[TBL] [Abstract][Full Text] [Related]
30. A feasibility study of interstitial hyperthermia plus external beam radiotherapy in glioblastoma multiforme using the Multi ELectrode Current Source (MECS) system.
Hulshof MC; Raaymakers BW; Lagendijk JJ; Koot RW; Crezee H; Stalpers LJ; González González D
Int J Hyperthermia; 2004 Aug; 20(5):451-63. PubMed ID: 15277019
[TBL] [Abstract][Full Text] [Related]
31. Results of interstitial brachytherapy for malignant brain tumors.
Mayr MT; Crocker IR; Butker EK; Williams H; Cotsonis GA; Olson JJ
Int J Oncol; 2002 Oct; 21(4):817-23. PubMed ID: 12239621
[TBL] [Abstract][Full Text] [Related]
32. Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.
Patel S; Breneman JC; Warnick RE; Albright RE; Tobler WD; van Loveren HR; Tew JM
Neurosurgery; 2000 May; 46(5):1123-8; discussion 1128-30. PubMed ID: 10807244
[TBL] [Abstract][Full Text] [Related]
33. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group.
Emami B; Scott C; Perez CA; Asbell S; Swift P; Grigsby P; Montesano A; Rubin P; Curran W; Delrowe J; Arastu H; Fu K; Moros E
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1097-104. PubMed ID: 8600093
[TBL] [Abstract][Full Text] [Related]
34. Brachytherapy of brain tumors.
Sneed PK; Gutin PH; Prados MD; Phillips TL; Weaver KA; Wara WM; Larson DA
Stereotact Funct Neurosurg; 1992; 59(1-4):157-65. PubMed ID: 1338231
[TBL] [Abstract][Full Text] [Related]
35. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost.
Sneed PK; Gutin PH; Larson DA; Malec MK; Phillips TL; Prados MD; Scharfen CO; Weaver KA; Wara WM
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):719-27. PubMed ID: 8040017
[TBL] [Abstract][Full Text] [Related]
36. Receipt of brachytherapy is an independent predictor of survival in glioblastoma in the Surveillance, Epidemiology, and End Results database.
Bartek J; Alattar AA; Dhawan S; Ma J; Koga T; Nakaji P; Dusenbery KE; Chen CC
J Neurooncol; 2019 Oct; 145(1):75-83. PubMed ID: 31471790
[TBL] [Abstract][Full Text] [Related]
37. Irradiation fields and doses in glioblastoma multiforme: are current standards adequate?
Reni M; Cozzarini C; Panucci MG; Ceresoli GL; Ferreri AJ; Fiorino C; Truci G; Falini A; Tartara F; Terreni MR; Verusio C; Villa E
Tumori; 2001; 87(2):85-90. PubMed ID: 11401212
[TBL] [Abstract][Full Text] [Related]
38. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
Panet-Raymond V; Souhami L; Roberge D; Kavan P; Shakibnia L; Muanza T; Lambert C; Leblanc R; Del Maestro R; Guiot MC; Shenouda G
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):473-8. PubMed ID: 18554821
[TBL] [Abstract][Full Text] [Related]
39. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
40. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
McDonald MW; Shu HK; Curran WJ; Crocker IR
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):130-6. PubMed ID: 20399036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
